Radiotherapy With Durvalumab Prior to Surgical Resection for HPV Negative Squamous Cell Carcinoma
Condition: Squamous Cell Carcinoma of the Head and Neck Interventions: Drug: Durvalumab; Radiation: Stereotactic Body Radiation Therapy (SBRT); Procedure: Standard of Care Therapy Sponsors: University of Colorado, Denver; AstraZeneca Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: AstraZeneca | Cancer & Oncology | Carcinoma | Radiation Therapy | Research | Skin Cancer | Squamous Cell Carcinoma